University of Reading cookie policy

We use cookies on to improve your experience, monitor site performance and tailor content to you

Read our cookie policy to find out how to manage your cookie settings

Parastou Donyai

Parastou Donyai
  • Ethics Representative, Pharmacy and Chemistry
  • Athena SWAN Representative, Pharmacy
  • Module Convenor and creator, 40-credit MPharm Year-4 module entitled Pharmacy and Society Projects (PM4PR2) from 2013
  • Programme Director and creator, MSc by Research in Pharmacy Practice from 2014

Postgraduate supervision

Prospective PhD students can email Professor Donyai directly with initial research proposals for further discussion.


A pharmacist with a PhD in Pharmacy, Professor Parastou Donyai also has a Postgraduate Diploma in Psychological Research Methods as well as a Degree in Psychology. Parastou's overarching theme of research, prescribing and medicines use, is supported by the application of social and psychological research methods. Specifically, Parastou's research examines the psychology of medication usage and discontinuation and decision-making processes. Parastou also has a longstanding research interest in continuing professional development in pharmacy.

Investigating prescribing in mental health. In collaboration with Berkshire Healthcare NHS Foundation Trust, this work involves the application of qualitative and quantitative methodology to build a model of current practice.

Professional development and revalidation. An examination of professional development records for revalidation of pharmacy professionals. A funded project commissioned by the then Royal Pharmaceutical Society of Great Britain on behalf of the Department of Health's research programme to support development of revalidation in pharmacy.

Professional bodies/affiliations

  • Member of Royal Pharmaceutical Society (RPS)
  • Member of General Pharmaceutical Council (GPhC)
  • Member of the British Association for Psychopharmacology (BAP)
  • Co-founder of the Academic Pharmacy Unit, a joint research venture with Berkshire Healthcare NHS Foundation Trust